6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Bacterial Meningitis: new trials by email Literature Review of Bacterial Meningitis trials Research Report on Bacterial Meningitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Confirmatory Study of BK1310 in Healthy Infants DPT-IPV-Hib, Hib vaccine, DPT-IPV - Tetanus, Diphtheria | Phase 3 | Completed | Tanabe Pharma Corporation | 267 | 2019-04-01 | 2026-01-06 |
| DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants DTaP-IPV/Hib Combined vaccine, DTaP-IPV vaccine and Hib vaccine - Tetanus, Diphtheria | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 424 | 2014-10-01 | 2022-04-25 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Immunochromatographic HAT tests (DSD), Card Agglutination Trypanosoma Test, TB POC Nucleic Acid Amplification Test (Molbio Diagnostics) - Neurological Disorders, Cerebral Malaria | Phase 3 | Completed | Institute of Tropical Medicine, Belgium | 352 | 2012-09-01 | 2016-01-18 |
| Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India Meningococcal ACWY conjugate vaccine - Bacterial Meningitis | Phase 3 | Completed | Novartis | 180 | 2012-03-01 | 2018-10-09 |
| Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan Meningococcal ACWY conjugate vaccine - Bacterial Meningitis | Phase 3 | Completed | Novartis | 341 | 2011-08-01 | 2014-09-22 |
| Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis Glycerol and paracetamol, Paracetamol, Placebo - Bacterial Meningitis | Phase 3 | Completed | Kamuzu University of Health Sciences | 466 | 2008-03-01 | 2012-07-10 |
Meningitis, Bacterial (6) · Diphtheria (2) · Poliomyelitis (2) · Tetanus (2) · Whooping Cough (2) · Haemophilus Infections (1) · Malaria, Cerebral (1) · Meningitis, Cryptococcal (1) · Neglected Diseases (1) · Nervous System Diseases (1) · Neurosyphilis (1) · Tuberculosis, Central Nervous System (1)
Bacterial Infections (6) · Bacterial Infections and Mycoses (6) · Central Nervous System Bacterial Infections (6) · Central Nervous System Diseases (6) · Central Nervous System Infections (6) · Infections (6) · Meningitis (6) · Neuroinflammatory Diseases (6) · Nervous System Diseases (5) · Actinomycetales Infections (3) · Gram-Negative Bacterial Infections (3) · Gram-Positive Bacterial Infections (3) · Bordetella Infections (2) · Clostridium Infections (2) · Corynebacterium Infections (2)
HibTITER protein, Haemophilus influenzae (2) · Acetaminophen (1) · Glycerol (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)
Novartis (2) · Institute of Tropical Medicine, Belgium (1) · Kamuzu University of Health Sciences (1) · Sanofi Pasteur, a Sanofi Company (1) · Tanabe Pharma Corporation (1)
Japan (2) · China (1) · Democratic Republic of the Congo (1) · India (1) · Malawi (1)
Dr. A Amaresh (1) · Dr. Nitya Gogtay (1) · Dr. Sanjay Lalwani (1) · Dr. Sharad Agarkhedkar (1) · Elizabeth M Molyneux, FRCPCH (1) · Emmanuel Bottieau, MD (1) · Li Min Huang, Dr. (1) · Marleen Boelaert, MD, PhD (1) · Nan Chang Chiu, Dr. (1) · Shu Jen Yeh, Dr. (1)